Latest Manufacturing Processes News

AdAlta has secured Australian manufacturing for its lead CAR-T therapy BZDS1901, which has shown rare complete tumour clearance in advanced mesothelioma patients. This move is a key step toward local clinical trials and boosts the therapy’s global commercial appeal.

1414 Degrees (ASX:14D) advances its SiNTL silicon anode technology, aiming to disrupt lithium-ion batteries in the rapidly expanding drone and UAV sector with higher capacity and faster charging.

Wide Open Agriculture appoints Craig Swan as CEO and pivots to a contract manufacturing model to improve economics and scale lupin protein production, while receiving a A$1.69 million R&D tax rebate.

AdAlta, Oribiotech, and Cell Therapies have inked a Memorandum of Understanding to deploy Oribiotech’s IRO automated cell therapy manufacturing platform in Australia and Asia Pacific, aiming to slash costs and boost production speed for CAR-T therapies.

Patrys has raised A$3.2 million through a share placement to fund its injectable quetiapine program’s Phase 1A clinical trial and FDA pre-IND preparations.

Mesoblast has acquired exclusive rights to a patented chimeric antigen receptor platform designed to enhance the targeting and potency of its mesenchymal stromal cell therapies, aiming to expand treatment options for inflammatory and autoimmune diseases.

Metal Powder Works has independently confirmed its DirectPowder™ CP Titanium Grade 2 feedstock meets stringent ASTM B384 structural standards via Laser Powder Bed Fusion, reinforcing its position in aerospace additive manufacturing.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) reported net sales of US$30.3 million for its FDA-approved cellular therapy Ryoncil in the March quarter, bringing total revenue since launch close to US$100 million. Strong sales in February and March offset January’s seasonal dip.

Weebit Nano Ltd (ASX: WBT) has opened a non-underwritten Share Purchase Plan (SPP) offering eligible shareholders in Australia and New Zealand the chance to buy up to A$30,000 worth of shares at A$4.05 each. The company aims to raise up to A$15 million to support the commercialisation of its Resistive RAM (ReRAM) technology.

BluGlass Limited (ASX: BLG) has entered a A$1.3 million strategic collaboration with a Fortune 500 global data storage company to advance photonics research using its proprietary visible laser technology.

Perpetual Resources has secured a significant tungsten exploration package in Brazil’s Seridó Mineral Province, aiming to capitalise on rising demand for this critical mineral amid global supply constraints.

AdAlta’s subsidiary AdCella has completed its first Joint Development Committee meeting with Shanghai Cell Therapy Group, advancing the development of the CAR-T therapy BZDS1901 with potential timeline acceleration and reduced regulatory risks.